What You Should Know:
– ScreenPoint Medical, a leading developer of AI-powered breast cancer detection solutions, today announced a key leadership change. Mark Koeniguer, who has served as CEO since 2022, is stepping down from his position.
– The company’s Board of Directors has appointed Pieter Kroese as the new Chief Executive Officer effective April 25, 2024.
– Mr. Kroese brings extensive experience to the role, having served as ScreenPoint’s COO for over five years. During his tenure as COO, he played a pivotal role in guiding the company’s transformation from a young startup into a thriving enterprise.
–
